Synapse Medicine

company

About

Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
€25M
Industries
Health Care,Medical,Medical Device,Pharmaceutical,Software
Founded date
Jan 1, 2017
Number Of Employee
51 - 100
Operating Status
Active

At Synapse Medicine, we believe in medication success, and are dedicated to creating the technology that makes it possible for everyone.

To achieve this goal, we have built an extensive global knowledge base for medication using algorithms to ensure the most reliable, up-to-date data. On the front-end, Synapse Medicine provides a SaaS platform and UI components that are used to prescribe, dispense, and manage medications across the entire patient journey.

Synapse is working with world-leading hospitals and digital health companies in the United States, Europe and Japan to transform today’s medication regimens into tomorrow’s medication success.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€25M
Synapse Medicine has raised a total of €25M in funding over 2 rounds. Their latest funding was raised on Mar 1, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 1, 2022 Series B €25M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Synapse Medicine is funded by 1 investors. Mutuelles Impact are the most recent investors.
Investor Name Lead Investor Funding Round
Mutuelles Impact Series B